Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients
- 7 September 2010
- journal article
- research article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 18 (10) , 685-691
Abstract
Summary. The hepatic venous pressure gradient (HVPG) is the gold standard for assessing portal pressure and correlates with the occurrence of portal hypertension (PH)–related complications. Transient elastography (TE) is a new, highly accurate noninvasive technique, which enables us to evaluate hepatic fibrosis to detect advanced fibrosis and cirrhosis. We performed a hepatic haemodynamic study and TE in 38 HIV/HCV‐coinfected patients. The association between HVPG and liver stiffness was assessed by linear regression. The diagnostic value of TE was assessed by receiver operating characteristic (ROC) curves. We considered clinically significant PH as an HVPG ≥10 mmHg and severe PH as an HVPG ≥12 mmHg. A total of 38 HIV/HCV‐coinfected patients were included. Twenty‐eight patients (73.7%) had clinically significant PH (HVPG ≥10 mmHg), and 23 (60.5%) of these had severe PH (HVPG ≥12 mmHg). We found a statistically significant association between liver stiffness (kPa) and HVPG (r2 = 0.46, P < 0.001, straight line equation HVPG=7.4 + 0.204*TE). The areas under the ROC curves were 0.80 [95% confidence interval (CI), 0.64–0.97] and 0.80 (95% CI, 0.66–0.94) for the prediction of HVPG ≥10 and ≥12 mmHg, respectively. Our data suggest that TE can predict the presence of clinically significant and severe PH in HIV/HCV‐coinfected patients.Keywords
This publication has 41 references indexed in Scilit:
- Hepatitis C and Human Immunodeficiency Virus Envelope Proteins Cooperatively Induce Hepatocytic Apoptosis via an Innocent Bystander MechanismThe Journal of Infectious Diseases, 2003
- Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency VirusClinical Infectious Diseases, 2003
- Hepatitis C and human immunodeficiency virus infectionHepatology, 2002
- Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐AnalysisClinical Infectious Diseases, 2001
- Mortality among Human Immunodeficiency Virus-Infected Patients with Cirrhosis or Hepatocellular Carcinoma Due to Hepatitis C Virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997Clinical Infectious Diseases, 2001
- Impact of Human Immunodeficiency Virus Infection on Progression to End‐Stage Liver Disease in Individuals with Hemophilia and Hepatitis C Virus InfectionThe Journal of Infectious Diseases, 2001
- Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2001
- Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patientsHepatology, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Human immunodeficiency virus infection modified the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosisJournal of Hepatology, 1997